  |
 |
1997 |
| 116.- |
Charco R, Margarit C y Allende H.
"Rechazo e inmunosupresión". En, Trasplante
Hepático . Hepatología Gastroenterología 1996;19:419-426 |
| 117.- |
Charco R, Jaurrieta E, Vargas V, Balsells
J, Murio JE, Lázaro JL, Margarit C and J. Martorell.
Relevance of positive lymphocytotoxic crossmatch and immunosuppressive
regimens in the outcome of liver transplants. Transplant Proc
1997;29:461-62 |
| 118.- |
Bilbao I., Hidalgo E, Lázaro
JL, Charco R, Balsells J, Murio JE, Cuadrado TF, Margarit C.
Risk factors for severe ischemic lesion after liver transplantion.
Transplant Proc 1997; 29:368-70 |
| 119.- |
Lázaro JL , Revhaug A, Murio JE.,
Balsells J., Charco R., Hidalgo E, Mora A, Cortés C, and Margarit
C. Haemodynamic study of the Piggy-back technique in liver
transplantation. Transplant Proc 1997;29:2851-52 |
| 120.- |
Martinez Ibáñez V , Vilchez
R , Ortega J , Iglesias J, Allende H, Margarit C, Matamoros
N and Español T. Relapse of sclerosing cholangitis after
liver transplantation in children with hyper-IgM syndrome. Transplant
Proc 1997;29:432-433 |
| 121.- |
Gavaldá J, Otero J, Murio
JE., Vargas V, Rosselló J, Galicó I, Margarit C,
Pahissa A. Two grams dayly of oral acyclovir reduces the incidence
of cytomegalovirus disease in CMV-seropositive liver transplant recipients.
Transplant Int 1997;10:462-465 |
|